Screening for Pancreatic Cancer in High-Risk Patients
Preliminary Evaluation of Screening for Pancreatic Cancer in Patients With Inherited Genetic Risk
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 200 (estimated)
- Sponsor
- Abramson Cancer Center at Penn Medicine · Other
This trial is looking for people who have specific genetic mutations or a family history of pancreatic cancer. Participants will undergo tests like endoscopic ultrasound or MRI to check for pancreatic lesions.
You may be able to join if
- I am at least 18 years old
- I have a BRCA1, BRCA2, ATM, or PALB2 mutation
- If my close family member has not had pancreatic cancer, I am at least 50 years old
- If my close family member has had pancreatic cancer, I am at least 10 years younger than they were when they were diagnosed
You may not be able to join if
- I am pregnant
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your EligibilityThe study is a prospective, observational study evaluating the utility of endoscopic ultrasound or MRI for the identification of preneoplastic and neoplastic pancreatic lesions in patients at high risk for pancreatic cancer, specifically those with BRCA1/2, ATM, or PALB2 mutations.
Loading trial locations…